Navigation Links
JCI table of contents: March 23, 2009
Date:3/23/2009

pher Baum, at Hannover Medical School, Germany, discuss the clinical importance of these data and the numerous questions that they pose for future research.

TITLE: The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

AUTHOR CONTACT:
Eugenio Montini
San Raffaele-Telethon Institute for Gene Therapy, Milan, Italy.
Phone: 39-02-26433869; Fax: 39-02-26434621, E-mail: montini.eugenio@hsr.it.

Luigi Naldini
San Raffaele-Telethon Institute for Gene Therapy, Milan, Italy.
Phone: 39-02-26434681; Fax: 39-02-26434621, E-mail: naldini.luigi@hsr.it.

View the PDF of this article at: https://www.the-jci.org/article.php?id=37630

ACCOMPANYING COMMENTARY
TITLE: Preventing and exploiting the oncogenic potential of integrating gene vectors

AUTHOR CONTACT:
Christopher Baum
Hannover Medical School, Hannover, Germany.
Phone: 49-511-532-6069; Fax: 49-511-532-6068; E-mail: baum.christopher@mh-hannover.de.

View the PDF of this article at: https://www.the-jci.org/article.php?id=38831


ONCOLOGY: Too much oxygen not a good thing for tumors

As tumors grow, some regions lack a blood supply adequate to maintain good levels of oxygen, that is some regions become hypoxic. This is a hallmark of malignant tumors and has been suggested, but not experimentally proven, to promote tumor progression. However, Paolo Michieli and colleagues, at the University of Turin Medical School, Italy, have now developed xenograft models to examine how human lung tumors without regions of hypoxia develop and found that tumors re
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. JCI table of contents: Sept. 4, 2007
4. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
5. Actavis Launches Carvedilol Tablets in the U.S.
6. Mylan Announces Final FDA Approval for Carvedilol Tablets
7. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
8. Actavis Launches Amlodipine Tablets in the U.S.
9. Implantable device designed to detect, stop seizures under study at MCG
10. Stevens Health, Technology and Society roundtable: Sept. 19
11. Fruity vegetables and fish reduce asthma and allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... store located in Mississippi. The premium frozen yogurt chain was listed as #22 on ... at 104 Railroad Avenue, New Albany, MS 38652, will have a grand opening event ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the ... July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite 200, ...
(Date:7/2/2015)... ... 02, 2015 , ... The American Association of Poison Control ... Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with the ... decrease drug overdose – especially of heroin and opioid medication – by expanding ...
(Date:7/2/2015)... ... 02, 2015 , ... Many Fourth of July celebrations will include fireworks this ... is sharing some tips to promote the proper use of fireworks. , According ... emergency room daily with fireworks-related injuries in the month surrounding the Fourth of July. ...
(Date:7/2/2015)... ... ... Patrick Achebe realized that the gift of poetry was fully in him, as beautiful phrases ... and three years later he was publishing an entire book of poetry. He knew there ... have always believed that the best way to lift yourself up, is in the effort ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... OAKS, Calif., May 28 Though most people are pulling ... the rule is insurance-covered treatments, like laser vein ... their varicose veins removed do not even realize that beautiful, ... covers the procedure. By not having varicose veins ...
... Chemical , one of the leading manufacturers of ... announced it plans to expand its sucralose capacity to ... next three years. The company also has the ... metric tons by 2014.(Logo: http://www.newscom.com/cgi-bin/prnh/20090528/CG23830LOGO )"Due to ...
... of Kerry Teel as President of Premier Anesthesia, a national anesthesia ... ... GA (Vocus) May 28, 2009 -- Jackson Healthcare announces ... national anesthesia management company based in Atlanta, Georgia., , , , ...
... StemCyte, Inc., a privately held cord blood bank ... 1,000th cord blood stem cell shipment for transplant. ... growth as one of the world,s leading providers ... http://www.newscom.com/cgi-bin/prnh/20090528/NY23885LOGO ...
... took a major step forward to save lives and ... $1 per pack surcharge into law. Additionally, the governor ... smoking cessation services for Floridians, including monies for the ... fourth lowest in the nation. When the surcharge goes ...
... Form Coalition to Mobilize Support for Local LTC EconomiesWASHINGTON, ... designed and launched this week as the voice and ... that support the long term care industry by providing ... of the nation,s elderly, announced today its opposition to ...
Cached Medicine News:Health News:Get Sexy Summer Legs From Renaissance Laser and Vein Institute (laserandveinclinic.com) Courtesy of Your Health Insurance 2Health News:Niutang to Expand Sucralose Capacity 66 Percent by 2012 2Health News:Kerry Teel Named President of Premier Anesthesia 2Health News:Kerry Teel Named President of Premier Anesthesia 3Health News:StemCyte, Inc. Reaches 1,000th Cord Blood Stem Cell Shipment for Transplant Milestone 2Health News:Florida's $1 Cigarette Tax Increase a Big Win for Public Health 2Health News:Florida's $1 Cigarette Tax Increase a Big Win for Public Health 3Health News:Community Businesses Impacted by Looming Cuts to Long Term Care Federal Funding 2Health News:Community Businesses Impacted by Looming Cuts to Long Term Care Federal Funding 3Health News:Community Businesses Impacted by Looming Cuts to Long Term Care Federal Funding 4
(Date:7/3/2015)... , July 3, 2015 ... Monitoring & Cardiac Rhythm Management Market ECG, Implantable ... Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, ... MarketsandMarkets, the global Cardiac Monitoring (CM) and Cardiac ... reach $26,646.5 Million by 2020 from $21,137.7 Million ...
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... 2015 ResMed Inc. (NYSE: RMD ) today ... year ended June 30, 2015 results on Thursday, July 30, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... for Tuesday, December 9 at 11:00 am ET to Discuss ... , SOUTH SAN FRANCISCO, Calif., Dec. ... SNSS ), a biopharmaceutical company focused on the development and ... its studies of voreloxin in acute myeloid leukemia (AML) will ...
... 1 Vical Incorporated (Nasdaq: VICL ) announced ... Merck & Co., Inc. based on Merck,s planned initiation of ... (pDNA) cancer vaccine. The candidate vaccine is based on Vical,s ... (hTERT). hTERT is the subject of separate license agreement. , ...
Cached Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2
... RM2125 microtome comes in two different versions ... RT. All RM2125 versions are now equipped ... the precision micrometer feeding system. The Leica ... function and specimen retraction as additional features. ...
... microtome with automatic fine/trim- feed system, ... precision cross roller bearings. For sectioning ... in biological, botany, and materials science. ... 90 mm can be accommodated. Performance, ...
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
... Infusion Catheter enables the physician to isolate ... and disperse the agent by means of ... is a multi-lumen catheter with two (2) ... infusion holes located between these balloons. When ...
Medicine Products: